NATTOKINASE DEGRADES THE SPIKE PROTEIN OF SARS COV2
in this way inhibits the entry of the virus into host cells
So in addition to using it as a Fibrinolytic, Anticoagulant,Antiplatelet
is added this effect against Viral Load of #Nattokinase doi.org/10.3390/molecu… #LongCovid#CFS
There are several other studies of the use of NATTOKINASE
In the link is a study that included 153patients with deep vein thrombosis,phlebitis or venous insufficiency
Conclude that NK represents an efficient/safe treatment in patien. with vascular diseases doi.org/10.3390/nu1306…
In this study
they point out that Nattokinase was superior in safety to t-PA, which is a traditional thrombolytic for IV use
A lower risk of bleeding was observed with the use of NK
And they conclude that NK is an excellent antithrombotic and with low risk doi.org/10.1007/s10068…
• • •
Missing some Tweet in this thread? You can try to
force a refresh
Study shows that LongCOVID and ME/CFS
are Hypoxic diseases doi.org/10.14814/phy2.…
Symptoms are due to Hypoxia/Hypoperfusion…(HHM)
We've known this for years
But we're still far from identifying
that the root causes are
Persistent Infections and SIBO/GIPO x.com/Aguirre1Gustav…
Viral persistence has already been sufficiently demonstrated
It was simple for us to do it since April2020
They should no longer spend on studies that do not provide solutions
There are several Antivirals
These studies are postponed
&DrugResistance advance
A LOW LEVEL OF OXYGEN IN THE MUSCLES
(HYPOXIA)
IS THE MOST FREQUENT CAUSE OF
CHRONIC FATIGUE
POST-EXERTIONAL MALAISE:PEM
NON-RESTORATIVE SLEEP
MUSCULOSKELETAL STIFFNESS AND PAIN WHEN WAKING UP
Histamine causes greater endothelial damage in COVID
by increasing the number of complement C3/C3b binding sites
on the surface of endothelial cells
This
is one more support for our Antihistamine Protocols
before starting Antivirals